Literature DB >> 21653964

Challenges to building capacity for evidence-based new vaccine policy in developing countries.

Jon Kim Andrus1, Barbara Jauregui, Lúcia Helena De Oliveira, Cuauhtémoc Ruiz Matus.   

Abstract

There are many challenges to ensuring that people in developing countries have equitable access to new vaccines. Two of the most important are having the capacity to make evidence-based new vaccine policy decisions in developing countries, and then when appropriate actually distributing those new vaccines to those who will most benefit from them. Based on our review of the Pan American Health Organization's ProVac Initiative in the Americas, we found that when national governments in developing countries develop the expertise to make the best technical decisions about immunization programs; take responsibility for helping to pay for and distribute vaccines; and are supported by strong partnerships with international organizations, they succeed in saving more lives more quickly.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21653964     DOI: 10.1377/hlthaff.2011.0361

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  8 in total

1.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

2.  Introduction of pentavalent vaccine in Indonesia: a policy analysis.

Authors:  Panji F Hadisoemarto; Michael R Reich; Marcia C Castro
Journal:  Health Policy Plan       Date:  2016-04-23       Impact factor: 3.344

3.  Ears of the Armadillo: Global Health Research and Neglected Diseases in Texas.

Authors:  Jon Andrus; Maria Elena Bottazzi; Jennifer Chow; Karen A Goraleski; Susan P Fisher-Hoch; Jocelyn K Lambuth; Bruce Y Lee; Harold S Margolis; Joseph B McCormick; Peter Melby; Kristy O Murray; Rebeca Rico-Hesse; Jesus G Valenzuela; Peter J Hotez
Journal:  PLoS Negl Trop Dis       Date:  2013-06-27

4.  The composition of demand for newly launched vaccines: results from the pneumococcal and rotavirus vaccine introductions in Ethiopia and Malawi.

Authors:  B Adam Williams; Teklay Kidane; Geoffrey Chirwa; Neghist Tesfaye; Marta R Prescott; Soleine T Scotney; Moussa Valle; Sintayehu Abebe; Adija Tambuli; Bridget Malewezi; Tahir Mohammed; Emily Kobayashi; Emily Wootton; Renee Wong; Rahima Dosani; Hamsa Subramaniam; Jessica Joseph; Elif Yavuz; Aliza Apple; Yann Le Tallec; Alice Kang'ethe
Journal:  Health Policy Plan       Date:  2016-02-07       Impact factor: 3.344

5.  Social inequality and children's health in Africa: a cross sectional study.

Authors:  Tim B Heaton; Benjamin Crookston; Hayley Pierce; Acheampong Yaw Amoateng
Journal:  Int J Equity Health       Date:  2016-06-14

6.  Optimized supply chain model reduces health system costs in DRC.

Authors:  Dorothy Thomas; Eomba Motomoke; Jessica Crawford; Olivier Defawe; Archimede Makaya; Jean Willy Ngwato; Joel Bompongo; Jose Monzembela; Gabriella Ailstock; Emily Bancroft; Bvudzai Magadzire; Dominique Baabo; Noel Watson
Journal:  Vaccine       Date:  2021-06-12       Impact factor: 3.641

7.  Improved Global Capacity for Influenza Surveillance.

Authors:  Lauren S Polansky; Sajata Outin-Blenman; Ann C Moen
Journal:  Emerg Infect Dis       Date:  2016-06       Impact factor: 6.883

8.  When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs.

Authors:  Alyssa Bilinski; Peter Neumann; Joshua Cohen; Teja Thorat; Katherine McDaniel; Joshua A Salomon
Journal:  PLoS Med       Date:  2017-10-02       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.